Literature DB >> 28164202

A ubiquitous metal, difficult to track: towards an understanding of the regulation of titanium(iv) in humans.

Sergio A Loza-Rosas1, Manoj Saxena, Yamixa Delgado, Kavita Gaur, Mallesh Pandrala, Arthur D Tinoco.   

Abstract

Despite the ubiquitous nature of titanium(iv) and several examples of its beneficial behavior in different organisms, the metal remains underappreciated in biology. There is little understanding of how the metal might play an important function in the human body. Nonetheless, a new insight is obtained regarding the molecular mechanisms that regulate the blood speciation of the metal to maintain it in a nontoxic and potentially bioavailable form for use in the body. This review surveys the literature on Ti(iv) application in prosthetics and in the development of anticancer therapeutics to gain an insight into soluble Ti(iv) influx in the body and its long-term impact. The limitation in analytical tools makes it difficult to depict the full picture of how Ti(iv) is transported and distributed throughout the body. An improved understanding of Ti function and its interaction with biomolecules will be helpful in developing future technologies for its imaging in the body.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28164202      PMCID: PMC5397357          DOI: 10.1039/c6mt00223d

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  77 in total

1.  Phase I Clinical Trial of a Day-1, -3, -5 Every 3 WeeksPhase I Clinical Trial of Day-1, -3, -5 Every 3 Weeks Schedule with Titanocene Dichloride (MKT 5) in Patients with Advanced Cancer. (Phase I Study Group of the AIO of the German Cancer Society).

Authors:  K. Mross; P. Robben-Bathe; L. Edler; J. Baumgart; W.E. Berdel; H. Fiebig; C. Unger
Journal:  Onkologie       Date:  2000-12

2.  Production, processing and small animal PET imaging of titanium-45.

Authors:  Amy L Vāvere; Richard Laforest; Michael J Welch
Journal:  Nucl Med Biol       Date:  2005-02       Impact factor: 2.408

3.  Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride.

Authors:  M Guo; Z Guo; P J Sadler
Journal:  J Biol Inorg Chem       Date:  2001-09       Impact factor: 3.358

4.  Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride.

Authors:  M Guo; H Sun; H J McArdle; L Gambling; P J Sadler
Journal:  Biochemistry       Date:  2000-08-22       Impact factor: 3.162

5.  Structural effects of titanium citrate on the human erythrocyte membrane.

Authors:  M Suwalsky; F Villena; B Norris; M A Soto; C P Sotomayor; L Messori; P Zatta
Journal:  J Inorg Biochem       Date:  2005-01-05       Impact factor: 4.155

Review 6.  Antitumour metallocenes: structure-activity studies and interactions with biomolecules.

Authors:  M M Harding; G Mokdsi
Journal:  Curr Med Chem       Date:  2000-12       Impact factor: 4.530

7.  Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement.

Authors:  R M Urban; J J Jacobs; M J Tomlinson; J Gavrilovic; J Black; M Peoc'h
Journal:  J Bone Joint Surg Am       Date:  2000-04       Impact factor: 5.284

8.  Study of titanocene-DNA and molybdenocene-DNA interactions by inductively coupled plasma-atomic emission spectroscopy.

Authors:  José L Vera; Félix R Román; Enrique Meléndez
Journal:  Anal Bioanal Chem       Date:  2004-04-23       Impact factor: 4.142

Review 9.  Antitumor titanium compounds.

Authors:  Francesco Caruso; Miriam Rossi
Journal:  Mini Rev Med Chem       Date:  2004-01       Impact factor: 3.862

10.  Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrin.

Authors:  Janelle S Crossgrove; David D Allen; Bonny L Bukaveckas; Susan S Rhineheimer; Robert A Yokel
Journal:  Neurotoxicology       Date:  2003-01       Impact factor: 4.294

View more
  13 in total

1.  The role of citrate, lactate and transferrin in determining titanium release from surgical devices into human serum.

Authors:  Justin P Curtin; Minji Wang; Tianfan Cheng; Lijian Jin; Hongzhe Sun
Journal:  J Biol Inorg Chem       Date:  2018-04-05       Impact factor: 3.358

2.  Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.

Authors:  Sergio A Loza-Rosas; Alexandra M Vázquez-Salgado; Kennett I Rivero; Lenny J Negrón; Yamixa Delgado; Josué A Benjamín-Rivera; Angel L Vázquez-Maldonado; Timothy B Parks; Charlene Munet-Colón; Arthur D Tinoco
Journal:  Inorg Chem       Date:  2017-06-23       Impact factor: 5.165

3.  Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.

Authors:  Manoj Saxena; Sergio A Loza-Rosas; Kavita Gaur; Shweta Sharma; Sofia C Pérez Otero; Arthur D Tinoco
Journal:  Coord Chem Rev       Date:  2018-03-20       Impact factor: 22.315

4.  Are cucurbiturils better drug carriers for bent metallocenes? Insights from theory.

Authors:  Dhurairajan Senthilnathan; Rajadurai Vijay Solomon; Shanmugam Kiruthika; Ponnambalam Venuvanalingam; Mahesh Sundararajan
Journal:  J Biol Inorg Chem       Date:  2018-03-03       Impact factor: 3.358

5.  Synthesis of asymmetrical diaminobis(alkoxo)-bisphenol compounds and their C1-symmetrical mono-ligated titanium(iv) complexes as highly stable highly active antitumor compounds.

Authors:  Gilad Nahari; Edit Y Tshuva
Journal:  Dalton Trans       Date:  2021-05-04       Impact factor: 4.390

6.  Synthesis of Pure Enantiomers of Titanium(IV) Complexes with Chiral Diaminobis(phenolato) Ligands and Their Biological Reactivity.

Authors:  Maya Miller; Edit Y Tshuva
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

7.  Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug.

Authors:  Maya Miller; Anna Mellul; Maya Braun; Dana Sherill-Rofe; Emiliano Cohen; Zohar Shpilt; Irene Unterman; Ori Braitbard; Jacob Hochman; Edit Y Tshuva; Yuval Tabach
Journal:  iScience       Date:  2020-06-12

Review 8.  Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization.

Authors:  Israel Rodríguez; Ritika Gautam; Arthur D Tinoco
Journal:  Biomimetics (Basel)       Date:  2020-12-30

9.  In vitro combinations of inert phenolato Ti(iv) complexes with clinically employed anticancer chemotherapy: synergy with oxaliplatin on colon cells.

Authors:  N Ganot; E Y Tshuva
Journal:  RSC Adv       Date:  2018-02-06       Impact factor: 4.036

10.  In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs.

Authors:  Nitzan Ganot; Ori Briaitbard; Asaad Gammal; Joseph Tam; Jacob Hochman; Edit Y Tshuva
Journal:  ChemMedChem       Date:  2018-10-19       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.